|Bid||4.1000 x 4000|
|Ask||4.1100 x 2200|
|Day's range||4.0900 - 4.4100|
|52-week range||2.1200 - 13.6800|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||5.38|
Investors continue to slowly move away from worries about the economy, inflation, and interest rates, sending growth stocks higher. It's not all good news and positivity, though.
Shares of genetic data healthcare company 23andMe (NASDAQ: ME) jumped higher on Monday morning, as did many other beaten-down stocks. It seems the market is willing to take a bet on this stock before the company reports financial results today after the market closes. 23andMe is scheduled to report financial results for the first quarter of its fiscal 2023 today after the market closes, followed by a conference call at 4:30 p.m. ET.
Yahoo Finance’s Ines Ferré joins the Live show to break down how stocks are performing after the June jobs report was released.